You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Expanded human NK cells from lung cancer patients sensitize patients’ PDL1−negative tumors to PD1-blockade therapy

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Expanded human NK cells from lung cancer patients sensitize patients’ PDL1−negative tumors to PD1-blockade therapy

 

Online download statistics by month:

Online download statistics by month: January 2021 to September 2024

AbstractFullPdf
Jan 2021416415259
Feb 2021379380163
Mar 202117717669
Apr 202115115171
May 202121321349
Jun 202116216250
Jul 202114014042
Aug 202111211240
Sep 202111111145
Oct 202115715752
Nov 202117517449
Dec 202113513751
Jan 2022818532
Feb 2022797932
Mar 2022929346
Apr 202210410939
May 2022677127
Jun 20229710439
Jul 20229710034
Aug 2022959731
Sep 202211311651
Oct 2022999949
Nov 2022868846
Dec 2022565617
Jan 2023565714
Feb 202310010017
Mar 2023555616
Apr 2023272733
May 2023222218
Jun 2023474722
Jul 2023363622
Aug 2023292921
Sep 202330305
Oct 2023898924
Nov 202321221218
Dec 2023474715
Jan 2024495023
Feb 2024454524
Mar 2024606079
Apr 2024616133
May 2024373525
Jun 2024494822
Jul 2024454634
Aug 2024232259
Sep 2024242525
Total453745691932